Yamada Harumi 山田治美

Researcher Number	70433620
Other IDs
Affiliation (based on the past Project Information) *help	2016 – 2019: 国際医療福祉大学, 薬学部, 教授
Review Section/Research Field	Principal Investigator Medical pharmacy Except Principal Investigator Medical pharmacy
Keywords	Principal Investigator 臨床 / 癌 / 薬学 / 抹消神経障害 / 冷感受容体 / 牛車腎気丸 / 末梢神経障害 / オキサリプラチン / 漢方薬 / 副作用 / 末しょう神経障害 / 白金系抗がん剤 … More Except Principal Investigator … More 薬学 / Direct Acting Antivirals / 遺伝子多型 / Direct Acting Antiviral / C型肝炎治療薬 / HCV / C型肝炎 / 薬物動態学 / 薬理遺伝学 / CYP3A4 / CYP3A5*3 / CYP3A5 Less

A study on the avoidance of side effects of Chinese herbal medicine on neuropathy caused by platinum-based anti-cancer drugs in clinical practicePrincipal Investigator
- Principal Investigator
  
  Yamada Harumi
- Project Period (FY)
  2016 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  International University of Health and Welfare
Pharmacogenetic study on anti-hepatitis C drugs based on CYP3A5 polymorphisms
- Principal Investigator
  
  Matsumoto Jun
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Okayama University
  International University of Health and Welfare

All 2019 2018 2017

All Journal Article Presentation

[Journal Article] Rokumigan alleviates oxaliplatin‐induced cold hypersensitivity by suppression of transient receptor potential cation channel subfamily M member 8 and subfamily A member 12019
- Author(s)
  Shimizu Kanako、Kato Yoshinori、Nakamura Hiroyoshi、Yamada Harumi
- Journal Title
  
  Traditional & Kampo Medicine
  
  Volume: 6 Issue: 1 Pages: 32-36
- DOI
  10.1002/tkm2.1205
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08411
[Journal Article] A proposed simple screening method to determine relative contributions of CYP3A4 and CYP3A5 to drug metabolism in vitro2019
- Author(s)
  Jun Matsumoto, Hiroyoshi Nakamura, Su Nwe San, Hikari Sato, Manami Takezawa, Ryuto Kishi, Yutaro Kito, Junko Sugano, Mai Izuki, Nao Yanagisawa, Naoki Ikeda, Yusuke Saito, Yoshinori Kato, Harumi Yamada, Masachika Fujiyoshi, and Noritaka Ariyoshi
- Journal Title
  
  Personalized Medicine Universe
  
  Volume: 印刷中
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K18955
[Journal Article] Analysis of Risk Factors for Oxaliplatin-Induced Acute Peripheral Neuropathy2018
- Author(s)
  Shimizu Kanako、Kato Yoshinori、Nakamura Hiroyoshi、Yamada Harumi
- Journal Title
  
  Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
  
  Volume: 44 Issue: 12 Pages: 623-630
- DOI
  10.5649/jjphcs.44.623
- NAID
  130007760381
- ISSN
  1346-342X, 1882-1499
- Year and Date
  2018-12-10
- Language
  Japanese
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K08411
[Journal Article] Determination of sofosbuvir via a high-performance liquid chromatography method using ultraviolet detection2018
- Author(s)
  Su Nwe San, Jun Matsumoto, Masako Koike, Yumi Saito, Hiroaki Sakaue, Yoshinori Kato, Noritaka Ariyoshi, and Harumi Yamada
- Journal Title
  
  Journal of International University of Health and Welfare
  
  Volume: 23 (1) Pages: 130-136
- NAID
  120006461263
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K18955
[Journal Article] オキサリプラチンによる急性末梢神経障害発症の危険因子の解析2018
- Author(s)
  清水加奈子，加藤芳徳，中村裕義，山田治美1
- Journal Title
  
  医療薬学
  
  Volume: 44 Pages: 623-630
- NAID
  130007760381
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K08411
[Journal Article] Determination of sofosbuvir via a high-performance liquid chromatography method using ultraviolet detection2018
- Author(s)
  Su Nwe San, Jun Matsumoto, Masako Koike, Yumi Saito, Hiroaki Sakaue, Yoshinori Kato, Noritaka Ariyoshi and Harumi Yamada
- Journal Title
  
  Journal of International University of Health and Welfare
  
  Volume: 23 Pages: 130-6
- NAID
  120006461263
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K18955
[Journal Article] Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro2018
- Author(s)
  Su Nwe San, Jun Matsumoto, Yumi Saito, Masako Koike, Hiroaki Sakaue, Yoshinori Kato, Masachika Fujiyoshi, Noritaka Ariyoshi, and Harumi Yamada
- Journal Title
  
  Xenobiotica
  
  Volume: 印刷中 Issue: 8 Pages: 935-944
- DOI
  10.1080/00498254.2018.1524947
- NAID
  120006768491
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K18955
[Presentation] 早期発症オキサリプラチン誘発性末梢神経障害の危険因子の探索2019
- Author(s)
  清水加奈子, 加藤芳徳, 中村裕義, 山田治美
- Organizer
  第27回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-16K08411
[Presentation] オキサリプラチン誘発性末梢神経障害発症に及ぼす関連因子に関する研究2019
- Author(s)
  篠加奈子, 加藤芳徳, 中村裕義, 山田治美
- Organizer
  日本薬学会137年会
- Data Source
  KAKENHI-PROJECT-16K08411
[Presentation] Contribution of CYP3A5 to the metabolism of direct acting anti-hepatitis C virus drugs asunaprevir, daclatasvir, and beclabuvir (Ximency) in vitro2018
- Author(s)
  Jun Matsumoto, Su New San, Ayano Kawauchi, Shiho Yanaka, Natsumi Chiba, Ran Tagai, Ryoko Sanbe, Masachika Fujiyoshi, Harumi Yamada, and Noritaka Ariyoshi
- Organizer
  The 24th International Congress of Personalized Medicine
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K18955
[Presentation] Minor contribution of cytochrome P450 3A5 to the metabolism of hepatitis C NS5B inhibitor beclabuvir in vitro2018
- Author(s)
  Su Nwe San, Jun Matsumoto, Yumi Saito, Masako Koike, Hiroaki Sakaue, Yoshinori Kato, Masachika Fujiyoshi, Noritaka Ariyoshi, and Harumi Yamada
- Organizer
  第28回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-16K18955
[Presentation] 早期発症オキサリプラチン誘発性末梢神経障害と化学療法レジメン中の体表面積当たりのオキサリプラチン量との関連性2018
- Author(s)
  加藤芳徳, 篠加奈子,中村裕義, 山田治美
- Organizer
  第28回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-16K08411
[Presentation] Minor contribution of human cytochrome 3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro2018
- Author(s)
  Su Nwe San, Jun Matsumoto, Yumi Saito, Masako Koike, Hiroaki Sakaue, Yoshinori Kato, Masachika Fujiyoshi, Noritaka Ariyoshi, and Harumi Yamada
- Organizer
  2018 International Meeting on 22nd MDO and 33rd JSSX
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K18955
[Presentation] オキサリプラチン誘発性末梢神経障害発症に及ぼす関連因子に関する研究2017
- Author(s)
  篠加奈子, 加藤芳徳, 中村裕義, 山田治美
- Organizer
  日本薬学会第137年会
- Place of Presentation
  仙台国際センター
- Year and Date
  2017-03-24
- Data Source
  KAKENHI-PROJECT-16K08411
[Presentation] 早期発症オキサリプラチン誘発性末梢神経障害の危険因子の探索2017
- Author(s)
  篠加奈子, 加藤芳徳, 中村裕義, 山田治美
- Organizer
  第27回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-16K08411

1. Matsumoto Jun (60709012)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
2. Ariyoshi Noritaka (00243957)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
3. Fujiyoshi Masachika (50751921)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
4. Nakamura Hiroyoshi

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

Yamada Harumi 山田 治美

Research Projects

Research Products

Co-Researchers

A study on the avoidance of side effects of Chinese herbal medicine on neuropathy caused by platinum-based anti-cancer drugs in clinical practicePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Pharmacogenetic study on anti-hepatitis C drugs based on CYP3A5 polymorphisms

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Rokumigan alleviates oxaliplatin‐induced cold hypersensitivity by suppression of transient receptor potential cation channel subfamily M member 8 and subfamily A member 12019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A proposed simple screening method to determine relative contributions of CYP3A4 and CYP3A5 to drug metabolism in vitro2019

Author(s)

Journal Title

Data Source

[Journal Article] Analysis of Risk Factors for Oxaliplatin-Induced Acute Peripheral Neuropathy2018

Author(s)

Journal Title

DOI

NAID

ISSN

Year and Date

Language

Data Source

[Journal Article] Determination of sofosbuvir via a high-performance liquid chromatography method using ultraviolet detection2018

Author(s)

Journal Title

NAID

Data Source

[Journal Article] オキサリプラチンによる急性末梢神経障害発症の危険因子の解析2018

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Determination of sofosbuvir via a high-performance liquid chromatography method using ultraviolet detection2018

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro2018

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] 早期発症オキサリプラチン誘発性末梢神経障害の危険因子の探索2019

Author(s)

Organizer

Data Source

[Presentation] オキサリプラチン誘発性末梢神経障害発症に及ぼす関連因子に関する研究2019

Author(s)

Organizer

Data Source

[Presentation] Contribution of CYP3A5 to the metabolism of direct acting anti-hepatitis C virus drugs asunaprevir, daclatasvir, and beclabuvir (Ximency) in vitro2018

Author(s)

Organizer

Data Source

[Presentation] Minor contribution of cytochrome P450 3A5 to the metabolism of hepatitis C NS5B inhibitor beclabuvir in vitro2018

Author(s)

Organizer

Data Source

[Presentation] 早期発症オキサリプラチン誘発性末梢神経障害と化学療法レジメン中の体表面積当たりのオキサリプラチン量との関連性2018

Author(s)

Organizer

Data Source

[Presentation] Minor contribution of human cytochrome 3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro2018

Author(s)

Organizer

Data Source

[Presentation] オキサリプラチン誘発性末梢神経障害発症に及ぼす関連因子に関する研究2017

Yamada Harumi 山田治美